Dividends & Buybacks ·
Medicus Pharma consolidates shares 50-to-1 to regain Nasdaq minimum bid price compliance
MDCXMedicus Pharma Ltd.
Medicus Pharma Ltd. announced a fifty-to-one share consolidation of its common shares, effective October 12, 2026. The move aims to increase the bid price and restore compliance with Nasdaq Capital Market listing requirements. Shareholders will exchange every 50 pre-consolidation shares for one new share, with fractional shares rounded down and paid in cash. Proportionate adjustments apply to warrants and equity awards. Medicus Pharma Ltd. operates in the biopharmaceutical industry.